Dainippon Sumitomo Pharma Acquires Boston Biomedical for $2,630,000,000

  • Feed Type
  • Date
    3/2/2012
  • Company Name
    Boston Biomedical
  • Mailing Address
    333 Providence Hwy. Norwood, MA 02062
  • Company Description
    Boston Biomedical, Inc. is a privately held biotechnology company focusing on research and development of novel therapeutics to treat cancer.
  • Website
    http://www.Bostonbiomedical.com
  • Transaction Type
    M&A
  • Transaction Amount
    $2,630,000,000
  • Transaction Round
  • Proceeds Purposes
  • M&A Terms
    DSP will acquire BBI for up to $2.63 billion in total which includes $200 million upfront, up to $540 million in development milestone payments, and up to $1.89 billion in sales milestone payments.

By posting a comment, you agree to our terms and conditions.